Clinic
Premier Medical Group of Mississippi LLC
Premier Medical Group of Mississippi LLC was paid $8.12M by Medicaid between Jan 2018 and Dec 2024, across 118 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 68% of everything it billed.
33Billing provider infoPREMIER MEDICAL GROUP OF MISSISSIPPI LLC
KOSCIUSKO, MS 39090
KOSCIUSKO, MS 39090
33aNPI1790827038assigned 02/13/2007
33bProvider typeClinic/Center
28Total paid$8.12M
24GClaims250,143
24DCodes billed118
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Mississippi
Rank by total paid#3 of 95
Median peer was paid$70K
This provider vs. median116×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,751 | $1.56M | |
| 2019 | 44,241 | $1.46M | |
| 2020 | 33,705 | $1.12M | |
| 2021 | 46,772 | $1.56M | |
| 2022 | 40,314 | $1.22M | |
| 2023 | 23,815 | $723K | |
| 2024incomplete | 12,545 | $472K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 68% | 87,992 | 76,096 | $5.49M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7.3% | 17,481 | 5,240 | $593K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.9% | 34,499 | 29,981 | $397K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.0% | 4,765 | 4,336 | $243K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.0% | 1,932 | 1,845 | $161K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.9% | 4,980 | 4,603 | $150K |
| 87581 | 1.5% | 3,417 | 3,154 | $123K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 1,413 | 1,333 | $119K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.3% | 8,819 | 7,442 | $109K |
| 87428 | <1% | 3,388 | 3,077 | $66K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 6,586 | 6,203 | $65K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,685 | 3,513 | $60K |
106 more codes
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 645 | $59K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,318 | $44K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,924 | $41K |
| J0558 | Injection, penicillin g benzathine and penicillin g procaine, 100,000 units | <1% | 284 | $35K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,435 | $34K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,668 | $32K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,946 | $31K |
| 87400 | <1% | 3,086 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,678 | $26K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,862 | $25K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 733 | $22K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,589 | $20K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 221 | $18K |
| 82570 | <1% | 3,976 | $15K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 168 | $13K |
| 81001 | <1% | 3,151 | $9K | |
| 80061 | Lipid panel | <1% | 1,162 | $8K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 104 | $7K |
| 90474 | <1% | 682 | $7K | |
| 84450 | <1% | 1,184 | $6K | |
| 84460 | <1% | 1,190 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 203 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,051 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 465 | $4K |
| 87807 | <1% | 408 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 186 | $3K |
| 81003 | <1% | 1,406 | $3K | |
| 99381 | <1% | 25 | $2K | |
| 99173 | <1% | 784 | $2K | |
| 90686 | <1% | 1,062 | $2K | |
| 99490 | Ccm add 20min | <1% | 309 | $2K |
| 97162 | <1% | 42 | $2K | |
| 0011A | <1% | 61 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 30 | $2K |
| 92551 | <1% | 267 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 168 | $2K |
| 3044F | <1% | 284 | $2K | |
| 86308 | <1% | 336 | $2K | |
| 80076 | <1% | 320 | $2K | |
| 0012A | <1% | 41 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 203 | $1K |
| 0001A | <1% | 39 | $1K | |
| 99051 | <1% | 103 | $1K | |
| 0002A | <1% | 30 | $939.80 | |
| 0072A | <1% | 29 | $903.93 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 427 | $862.05 |
| 80305 | <1% | 161 | $854.49 | |
| 0071A | <1% | 19 | $688.71 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 137 | $585.53 |
| 99307 | <1% | 39 | $513.98 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 92 | $423.10 |
| 3288F | <1% | 148 | $370.38 | |
| 90682 | <1% | 60 | $332.44 | |
| G0008 | Administration of influenza virus vaccine | <1% | 113 | $285.56 |
| 74019 | <1% | 15 | $283.88 | |
| 99442 | <1% | 55 | $283.04 | |
| 95117 | <1% | 28 | $223.14 | |
| 87510 | <1% | 12 | $220.55 | |
| 85610 | <1% | 55 | $220.52 | |
| 87480 | <1% | 12 | $200.50 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 26 | $168.95 |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 64 | $148.27 |
| 82044 | <1% | 54 | $125.21 | |
| 1101F | <1% | 65 | $120.65 | |
| 81025 | <1% | 41 | $119.39 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 39 | $84.19 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 99 | $81.09 |
| 82948 | <1% | 17 | $62.69 | |
| 82947 | <1% | 14 | $51.34 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 13 | $46.03 |
| 93000 | <1% | 12 | $45.73 | |
| 99000 | <1% | 710 | $34.20 | |
| 85018 | <1% | 13 | $20.46 | |
| 90656 | <1% | 13 | $15.05 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 24 | $3.05 |
| 90697 | 0% | 78 | $0.00 | |
| 3011F | 0% | 80 | $0.00 | |
| 90698 | 0% | 239 | $0.00 | |
| 36416 | 0% | 180 | $0.00 | |
| 1126F | 0% | 309 | $0.00 | |
| 3075F | 0% | 23 | $0.00 | |
| 90723 | 0% | 202 | $0.00 | |
| 90647 | 0% | 85 | $0.00 | |
| 1036F | 0% | 815 | $0.00 | |
| 90696 | 0% | 37 | $0.00 | |
| 90651 | 0% | 170 | $0.00 | |
| 1034F | 0% | 39 | $0.00 | |
| 3074F | 0% | 409 | $0.00 | |
| 3079F | 0% | 100 | $0.00 | |
| 90744 | 0% | 54 | $0.00 | |
| 1125F | 0% | 46 | $0.00 | |
| 90677 | 0% | 32 | $0.00 | |
| 90681 | 0% | 568 | $0.00 | |
| 90670 | 0% | 1,222 | $0.00 | |
| 90648 | 0% | 461 | $0.00 | |
| 3078F | 0% | 445 | $0.00 | |
| 3077F | 0% | 76 | $0.00 | |
| 90734 | 0% | 116 | $0.00 | |
| 90715 | 0% | 164 | $0.00 | |
| 90710 | 0% | 69 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 70 | $0.00 |
| 1159F | 0% | 656 | $0.00 | |
| 90633 | 0% | 231 | $0.00 | |
| 1160F | 0% | 656 | $0.00 | |
| 90671 | 0% | 70 | $0.00 | |
| 90649 | 0% | 49 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTURNER, JACKEY (MEDICAL DIRECTOR)